Ticker Details
Theravance Biopharma, Inc. Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.
IPO Date:	May 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$883.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 2.26%
Avg Daily Range (30 D):	$0.03 | 0.15%
Avg Daily Range (90 D):	$0.17 | 1.00%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.46M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	110
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	2,349
Avg Institutional Trade:	$1.42M
Avg Institutional Trade (30 D):	$2.11M
Avg Institutional Trade (90 D):	$1.77M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.23M
Avg Closing Trade (30 D):	$1.24M
Avg Closing Trade (90 D):	$1.6M
Avg Closing Volume:	77.24K

News

Jul 16, 2026 @ 10:00 AM Zymeworks to Report Second Quarter 2026 Financial ... Source: Na

Jun 29, 2026 @ 10:00 AM Zymeworks to Acquire Theravance Biopharma, Inc. Source: Na

Apr 3, 2026 @ 12:48 AM TBPH Investors Have Opportunity to Join Theravance... Source: Schall Law Firm

Mar 3, 2026 @ 6:19 PM Theravance Biopharma Plummets As Phase 3 Study Fal... Source: Vandana Singh

Feb 22, 2026 @ 3:08 PM Irenic Dumps Most Papa John's Shares Source: Lawrence Rothman, Cfa

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.06	$-.11	$-.1
Diluted EPS	$1.01	$-.11	$-.1
Revenue	$104.31M	$20.73M	$17.7M
Gross Profit
Net Income / Loss	$53.81M	$-5.9M	$-4.93M
Operating Income / Loss	$-4.2M	$-8.28M	$-9.48M
Cost of Revenue
Net Cash Flow	$-62.16M	$-68.34M	$120.3M
PE Ratio